正大集团
- 网络CP GROUP;Charoen Pokphand;chia tai group
-
如果中国保监会今晚没有作出裁决,汇丰和正大集团可以选择将交易延期。
HSBC and CP Group could extend their deadline beyond tonight if the regulator makes no ruling .
-
昨天汇丰对其计划不予置评,而正大集团表示该集团并不打算终止交易。
HSBC would not comment on its plans yesterday , while CP Group said it had no plans to withdraw its offer .
-
为能进一步创造社会效益,正大集团也在教育领域向国内多所大学提供了资助。
To further create social benefits , CTG provides financial support to some Chinese universities with regard to education .
-
年,正大集团在中国改革开放的第一时间,领先进入中国市场,是世界上第一家投资中国的外资公司。
In1979 when China started to open its door to the outside world , the Chia Tai Group was among the first investors to enter the Chinese market .
-
2014年7月,正大集团和伊藤忠曾签署一份旨在发展农业合资企业的交叉持股协议,以便从中国确保食品和水供应安全的浓厚兴趣中获益。
CP Group and Itochu signed a cross-shareholding deal in July aimed at developing agribusiness ventures to tap China 's interest in securing a safe supply of food and water .
-
本文利用计量模型对反映中国零售业市场发展趋势的指标进行趋势分析,得到正大集团应该进入中国零售市场的结论。
We will utilize mathematics model to forecast the trend of the development of china retail market and draw a conclusion that Charoen Pokphand Group should step into china retail market .
-
在另外一份声明中,正大集团表示:通过在中国最大集团中持有相当数量的股份,正大集团和伊藤忠获得了参与中国增长的宝贵机遇。
In a separate statement , CPG said that : By owning a meaningful stake in China 's largest conglomerate , CP Group and Itochu are gaining a valuable opportunity to participate in China 's growth .
-
此外,中信集团还将与正大集团及伊藤忠执行一份战略合作协议,以借助他们各自的实力,在三方之间探索及捕捉在中国内地及全球市场的重要战略机遇。
Moreover , Citic will also enter a strategic cooperation agreement with CPG and Itochu to leverage their respective strengths to explore and capture important strategic opportunities among three parties in the PRC and the global markets .
-
中国企业集团概念的演化:背离与回归正大控股集团有限公司从属于泰国正大集团。
Study on the Evolution of the Conception of Business Groups in China ; CT Holdings is part of the C.P Group of Thailand .
-
但是,江苏的正大天晴药业集团股份有限公司所生产的产品每个月是4200元,江苏豪森药业股份有限公司的替代品每个月3800元。
But a generic version produced by Chia Tai Tianqing Pharmaceutical Group in Jiangsu Province cost 4200 yuan a month and another substitute , from Jiangsu Hansoh Pharmaceutical , cost 3800 yuan a month .